These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32340643)

  • 1. Association of extent of cannabis use and psychotic like intoxication experiences in a multi-national sample of first episode psychosis patients and controls.
    Sami M; Quattrone D; Ferraro L; Tripoli G; Cascia E; Gayer-Anderson C; Selten JP; Arango C; Bernardo M; Tarricone I; Tortelli A; Gatto G; Del Peschio S; Del-Ben CM; Rutten BP; Jones PB; van Os J; de Haan L; Morgan C; Lewis C; Bhattacharyya S; Freeman TP; Lynskey M; Murray RM; Forti MD
    Psychol Med; 2021 Sep; 51(12):2074-2082. PubMed ID: 32340643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily use of high-potency cannabis is associated with more positive symptoms in first-episode psychosis patients: the EU-GEI case-control study.
    Quattrone D; Ferraro L; Tripoli G; La Cascia C; Quigley H; Quattrone A; Jongsma HE; Del Peschio S; Gatto G; ; Gayer-Anderson C; Jones PB; Kirkbride JB; La Barbera D; Tarricone I; Berardi D; Tosato S; Lasalvia A; Szöke A; Arango C; Bernardo M; Bobes J; Del Ben CM; Menezes PR; Llorca PM; Santos JL; Sanjuán J; Tortelli A; Velthorst E; de Haan L; Rutten BPF; Lynskey MT; Freeman TP; Sham PC; Cardno AG; Vassos E; van Os J; Morgan C; Reininghaus U; Lewis CM; Murray RM; Di Forti M
    Psychol Med; 2021 Jun; 51(8):1329-1337. PubMed ID: 32183927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in cannabis-related experiences between patients with a first episode of psychosis and controls.
    Bianconi F; Bonomo M; Marconi A; Kolliakou A; Stilo SA; Iyegbe C; Gurillo Muñoz P; Homayoun S; Mondelli V; Luzi S; Dazzan P; Prata D; La Cascia C; O'Connor J; David A; Morgan C; Murray RM; Lynskey M; Di Forti M
    Psychol Med; 2016 Apr; 46(5):995-1003. PubMed ID: 26670601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do AKT1, COMT and FAAH influence reports of acute cannabis intoxication experiences in patients with first episode psychosis, controls and young adult cannabis users?
    Hindocha C; Quattrone D; Freeman TP; Murray RM; Mondelli V; Breen G; Curtis C; Morgan CJA; Valerie Curran H; Di Forti M
    Transl Psychiatry; 2020 May; 10(1):143. PubMed ID: 32398646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis.
    González-Blanco L; García-Portilla MP; Gutiérrez M; Mezquida G; Cuesta MJ; Urbiola E; Amoretti S; Barcones F; González-Pinto A; Pina-Camacho L; Corripio I; Vieta E; Baeza I; Toll A; Sáiz PA; Bobes J; Bernardo M;
    Schizophr Res; 2021 Oct; 236():19-28. PubMed ID: 34365082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tobacco use in first-episode psychosis, a multinational EU-GEI study.
    Sánchez-Gutiérrez T; Rodríguez-Toscano E; Roldán L; Ferraro L; Parellada M; Calvo A; López G; Rapado-Castro M; La Barbera D; La Cascia C; Tripoli G; Di Forti M; Murray RM; Quattrone D; Morgan C; van Os J; García-Portilla P; Al-Halabí S; Bobes J; de Haan L; Bernardo M; Santos JL; Sanjuán J; Arrojo M; Ferchiou A; Szoke A; Rutten BP; Stilo S; D'Andrea G; Tarricone I; ; Díaz-Caneja CM; Arango C
    Psychol Med; 2023 Nov; 53(15):7265-7276. PubMed ID: 37185055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent contribution of polygenic risk for schizophrenia and cannabis use in predicting psychotic-like experiences in young adulthood: testing gene × environment moderation and mediation.
    Elkrief L; Lin B; Marchi M; Afzali MH; Banaschewski T; Bokde ALW; Quinlan EB; Desrivières S; Flor H; Garavan H; Gowland P; Heinz A; Ittermann B; Martinot JL; Martinot MP; Nees F; Orfanos DP; Paus T; Poustka L; Hohmann S; Fröhner JH; Smolka MN; Walter H; Whelan R; Schumann G; Luykx J; Boks MP; Conrod PJ;
    Psychol Med; 2023 Apr; 53(5):1759-1769. PubMed ID: 37310336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing evidence supporting cannabis harm reduction practices for adolescents at clinical high-risk for psychosis: a review and clinical implementation tool.
    Kapler S; Adery L; Hoftman GD; Amir CM; Grigoryan V; Cooper ZD; Bearden CE
    Psychol Med; 2024 Jan; 54(2):245-255. PubMed ID: 37882050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study.
    Quattrone D; Reininghaus U; Richards AL; Tripoli G; Ferraro L; Quattrone A; Marino P; Rodriguez V; Spinazzola E; Gayer-Anderson C; Jongsma HE; Jones PB; La Cascia C; La Barbera D; Tarricone I; Bonora E; Tosato S; Lasalvia A; Szöke A; Arango C; Bernardo M; Bobes J; Del Ben CM; Menezes PR; Llorca PM; Santos JL; Sanjuán J; Arrojo M; Tortelli A; Velthorst E; Berendsen S; de Haan L; Rutten BPF; Lynskey MT; Freeman TP; Kirkbride JB; Sham PC; O'Donovan MC; Cardno AG; Vassos E; van Os J; Morgan C; Murray RM; Lewis CM; Di Forti M;
    Transl Psychiatry; 2021 Aug; 11(1):423. PubMed ID: 34376640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.
    Trotta G; Rodriguez V; Quattrone D; Spinazzola E; Tripoli G; Gayer-Anderson C; Freeman TP; Jongsma HE; Sideli L; Aas M; Stilo SA; La Cascia C; Ferraro L; La Barbera D; Lasalvia A; Tosato S; Tarricone I; D'Andrea G; Tortelli A; Schürhoff F; Szöke A; Pignon B; Selten JP; Velthorst E; de Haan L; Llorca PM; Rossi Menezes P; Del Ben CM; Santos JL; Arrojo M; Bobes J; Sanjuán J; Bernardo M; Arango C; Kirkbride JB; Jones PB; Richards A; Rutten BP; Van Os J; Austin-Zimmerman I; Li Z; Morgan C; Sham PC; Vassos E; Wong C; Bentall R; Fisher HL; Murray RM; Alameda L; Di Forti M;
    Psychol Med; 2023 Nov; 53(15):7375-7384. PubMed ID: 38078747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study.
    Gerlach J; Koret B; Gereš N; Matić K; Prskalo-Čule D; Zadravec Vrbanc T; Lovretić V; Skopljak K; Matoš T; Šimunović Filipčić I; Filipčić I
    Psychiatr Danub; 2019 Jun; 31(Suppl 2):162-170. PubMed ID: 31158117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study.
    Spinazzola E; Quattrone D; Rodriguez V; Trotta G; Alameda L; Tripoli G; Gayer-Anderson C; Freeman TP; Johnson EC; Jongsma HE; Stilo S; La Cascia C; Ferraro L; La Barbera D; Lasalvia A; Tosato S; Tarricone I; D'Andrea G; Galatolo M; Tortelli A; Tagliabue I; Turco M; Pompili M; Selten JP; de Haan L; Rossi Menezes P; Del Ben CM; Santos JL; Arrojo M; Bobes J; Sanjuán J; Bernardo M; Arango C; Kirkbride JB; Jones PB; O'Donovan M; Rutten BP; Van Os J; Morgan C; Sham PC; Austin-Zimmerman I; Li Z; Vassos E; ; Murray RM; Di Forti M
    Psychol Med; 2023 Nov; 53(15):7418-7427. PubMed ID: 37129249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms.
    Ricci V; Martinotti G; Ceci F; Chiappini S; Di Carlo F; Burkauskas J; Susini O; Luciani D; Quattrone D; De Berardis D; Pettorruso M; Maina G; Di Giannantonio M
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study.
    D'Andrea G; Quattrone D; Malone K; Tripoli G; Trotta G; Spinazzola E; Gayer-Anderson C; Jongsma HE; Sideli L; Stilo SA; La Cascia C; Ferraro L; Lasalvia A; Tosato S; Tortelli A; Velthorst E; de Haan L; Llorca PM; Rossi Menezes P; Santos JL; Arrojo M; Bobes J; Sanjuán J; Bernardo M; Arango C; Kirkbride JB; Jones PB; Rutten BP; Van Os J; Selten JP; Vassos E; Schürhoff F; Szöke A; Pignon B; O'Donovan M; Richards A; Morgan C; Di Forti M; Tarricone I; Murray RM
    Psychol Med; 2024 Jun; 54(8):1810-1823. PubMed ID: 38288603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study.
    Di Forti M; Marconi A; Carra E; Fraietta S; Trotta A; Bonomo M; Bianconi F; Gardner-Sood P; O'Connor J; Russo M; Stilo SA; Marques TR; Mondelli V; Dazzan P; Pariante C; David AS; Gaughran F; Atakan Z; Iyegbe C; Powell J; Morgan C; Lynskey M; Murray RM
    Lancet Psychiatry; 2015 Mar; 2(3):233-8. PubMed ID: 26359901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.
    Di Forti M; Quattrone D; Freeman TP; Tripoli G; Gayer-Anderson C; Quigley H; Rodriguez V; Jongsma HE; Ferraro L; La Cascia C; La Barbera D; Tarricone I; Berardi D; Szöke A; Arango C; Tortelli A; Velthorst E; Bernardo M; Del-Ben CM; Menezes PR; Selten JP; Jones PB; Kirkbride JB; Rutten BP; de Haan L; Sham PC; van Os J; Lewis CM; Lynskey M; Morgan C; Murray RM;
    Lancet Psychiatry; 2019 May; 6(5):427-436. PubMed ID: 30902669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
    Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
    J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study.
    Seddon JL; Birchwood M; Copello A; Everard L; Jones PB; Fowler D; Amos T; Freemantle N; Sharma V; Marshall M; Singh SP
    Schizophr Bull; 2016 May; 42(3):619-25. PubMed ID: 26536902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute cannabis use causes increased psychotomimetic experiences in individuals prone to psychosis.
    Mason O; Morgan CJ; Dhiman SK; Patel A; Parti N; Patel A; Curran HV
    Psychol Med; 2009 Jun; 39(6):951-6. PubMed ID: 19017430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Cannabis Use in People with Psychosis.
    Chesney E; Lawn W; McGuire P
    Cannabis Cannabinoid Res; 2024 Feb; 9(1):49-58. PubMed ID: 37971872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.